Safety and efficacy of prophylactic resorbable biosynthetic mesh following midline laparotomy in clean/contemned field: preliminary results of a randomized double blind prospective trial

被引:13
|
作者
Pizza, F. [1 ]
D'Antonio, D. [1 ]
Arcopinto, M. [2 ]
Dell'Isola, C. [3 ]
Marvaso, A. [1 ]
机构
[1] ASL Napoli 2 Nord, Via Lupoli 27, I-80027 Naples, Italy
[2] AORN A Cardarelli, Naples, Italy
[3] AORN Azienda Colli A Cotugno, Naples, Italy
关键词
Incisional hernia; Resorb able mesh; Prophylactic mesh; INCISIONAL HERNIA; VENTRAL HERNIA; CLINICAL-TRIAL; ABDOMINAL-WALL; REINFORCEMENT; METAANALYSIS; PREVENTION; CLOSURE; COMPLICATIONS; INFECTIONS;
D O I
10.1007/s10029-019-02025-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Incisional hernia (IH) is one of the most common sequelae of laparotomy. Materials and methods We present a double-blind randomized study examining feasibility, safety and incisional hernia rate using a prophylactic Bio-A biosynthetic stripe (Gore) in a sub-lay position after midline laparotomy in patients undergoing operations in clean-contaminated and contaminated field. One hundred patients who underwent a midline laparotomy of at least 10 cm in a clean-contaminated and contaminated field were considered. Patients were divided into two groups: [Group A closed in double layer using PDS 0 with WL/SL of 1:4; Group B closure in double layer using PDS 0 and sub-lay positioning a 3 cm-wide BIO A (Gore) strip extended for the entire length of the incision]. The primary objective of the study was to identify IH rate in the two groups at 1- and 2-year follow-up. Secondary objective was to identify any differences in the two groups in terms of post-operative pain, morbidity and mortality. Results Out of a total of 100 patients included in the study, a 2-year follow-up was possible for 47 patients in group A and 45 in group B. The incidence of IH was 11/47 in group A (22%) and 3/45 in group B (6%) [p < 0.01]. Furthermore, no statistically significant difference was noted about post-operative morbidity and pain related to the wall closure method. Conclusions The prophylactic use of a BIO-A biosynthetic stripe (Gore) showed a statistically significant reduction in the incisional hernia rate in patients who underwent clean-contaminated and contaminated surgery.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 50 条
  • [41] A prospective randomized double-blind controlled trial to evaluate the efficacy of an analgesic epidural paste following lumbar decompressive surgery
    Hurlbert, RJ
    Theodore, N
    Drabier, JB
    Magwood, AM
    Sonntag, VKH
    JOURNAL OF NEUROSURGERY, 1999, 90 (04) : 191 - 197
  • [42] The efficacy of sensory nerve coaptation in DIEP flap breast reconstruction - Preliminary results of a double-blind randomized controlled trial
    Bubberman, Jeske M.
    Brandts, Lloyd
    van Kuijk, Sander M. J.
    van der Hulst, Rene R. W. J.
    Tuinder, Stefania M. H.
    BREAST, 2024, 74
  • [43] Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19
    Sabitov, Alebai U.
    Lioznov, Dmitry A.
    Zhdanov, Konstantin V.
    Tihonova, Elena P.
    Esaulenko, Elena V.
    Sorokin, Pavel V.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (03) : 280 - 285
  • [44] Efficacy and safety of avanafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Park, J. K.
    Zhao, C.
    Kim, S. W.
    Yang, D. Y.
    Kim, J. J.
    Park, N. C.
    Lee, S. W.
    Paick, J. S.
    Ahn, T. Y.
    Moon, K. H.
    Chung, W. S.
    Min, K. S.
    Suh, J. K.
    Hyun, J. S.
    Park, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E701 - U494
  • [45] Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial
    Zhao, Chen
    Kim, Sae Woong
    Yang, Dae Yul
    Kim, Je Jong
    Park, Nam Cheol
    Lee, Sung Won
    Paick, Jae Seung
    Ahn, Tai Young
    Moon, Ki Hak
    Chung, Woo Sik
    Min, Kweon Sik
    Suh, Jun-Kyu
    Hyun, Jae Seog
    Park, Kwangsung
    Park, Jong Kwan
    BJU INTERNATIONAL, 2012, 110 (11) : 1801 - 1806
  • [46] The Efficacy of Dextrose Prolotherapy for Temporomandibular Joint Hypermobility: A Preliminary Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Refai, Hamida
    Altahhan, Obada
    Elsharkawy, Rehab
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 69 (12) : 2962 - 2970
  • [47] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    van der Heijde, Desiree
    Kivitz, Alan
    Schiff, Michael H.
    Sieper, Joachim
    Dijkmans, Ben A. C.
    Braun, Juergen
    Dougados, Maxime
    Reveille, John D.
    Wong, Robert L.
    Kupper, Hartmut
    Davis, John C., Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146
  • [48] Results of a randomized, double-blind study to evaluate the efficacy and safety of etanercept in patients with psoriasis and psoriatic arthritis: the PRESTA trial
    Sterry, W.
    Ortonne, J. -P.
    Kirkham, B.
    Robertson, D.
    Molta, C.
    Pedersen, R.
    Freundlich, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1410 - 1411
  • [49] Generic glatiramer acetate is equivalent to copaxone on efficacy and safety: results of the randomized double-blind GATE trial in multiple sclerosis
    Cohen, J. A.
    Belova, A.
    Selmaj, K.
    Wolf, C.
    Oberye, J. J. L.
    van den Tweel, E. R. W.
    Koper, N. P.
    Voortman, G.
    Barkhof, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 38 - 39
  • [50] Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
    Lederman, Seth
    Arnold, Lesley M.
    Vaughn, Ben
    Kelley, Mary
    Sullivan, Gregory M.
    ARTHRITIS CARE & RESEARCH, 2023, 75 (11) : 2359 - 2368